1. New Technologies for the Identification of Novel Genetic Markers of Disorders of Sex Development (DSD)
- Author
-
A, Bashamboo, S, Ledig, P, Wieacker, J C, Achermann, J, Achermann, and K, McElreavey
- Subjects
Genetic Markers ,Paper ,Embryology ,Disorders of sex development ,Endocrinology, Diabetes and Metabolism ,Computational biology ,Biology ,DNA sequencing ,Structural variation ,03 medical and health sciences ,0302 clinical medicine ,Next generation sequencing ,medicine ,Humans ,Copy-number variation ,030304 developmental biology ,Genetics ,Comparative genomic hybridization ,0303 health sciences ,High-throughput sequencing ,Sequence Analysis, DNA ,medicine.disease ,Phenotype ,3. Good health ,Testis determining factor ,Genetic Techniques ,Genetic marker ,Identification (biology) ,030217 neurology & neurosurgery ,Developmental Biology - Abstract
Although the genetic basis of human sexual determination and differentiation has advanced considerably in recent years, the fact remains that in most subjects with disorders of sex development (DSD) the underlying genetic cause is unknown. Where pathogenic mutations have been identified, the phenotype can be highly variable, even within families, suggesting that other genetic variants are influencing the expression of the phenotype. This situation is likely to change, as more powerful and affordable tools become widely available for detailed genetic analyses. Here, we describe recent advances in comparative genomic hybridisation, sequencing by hybridisation and next generation sequencing, and we describe how these technologies will have an impact on our understanding of the genetic causes of DSD.
- Published
- 2010
- Full Text
- View/download PDF